Summary by Futu AI
Biodexa Pharmaceuticals PLC has officially announced the appointment of PKF Littlejohn LLP as its new independent registered public accounting firm, effective October 31, 2024. This change follows the resignation of the previous auditor, Forvis Mazars LLP (formerly known as Mazars LLP), which took effect on October 25, 2024. The decision came after Forvis Mazars LLP informed the company of their intention to resign and a subsequent tender process was conducted to select a new auditor. The Audit Committee and the Board of Directors of Biodexa Pharmaceuticals assessed the commercial terms and expertise of the tender participants before approving PKF Littlejohn LLP's appointment. Forvis Mazars LLP's audit reports for the fiscal years ended December 31, 2022, and 2023 did not contain any adverse opinion or disclaimer...Show More